A
Asher Kornbluth
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 111
Citations - 11331
Asher Kornbluth is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Ulcerative colitis & Inflammatory bowel disease. The author has an hindex of 37, co-authored 105 publications receiving 10459 citations. Previous affiliations of Asher Kornbluth include Mount Sinai Hospital & City University of New York.
Papers
More filters
Journal ArticleDOI
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Jean-Frederic Colombel,William J. Sandborn,Walter Reinisch,Gerassimos J. Mantzaris,Asher Kornbluth,Daniel Rachmilewitz,Simon Lichtiger,Robert H. Diamond,Delma L. Broussard,Kezhen L. Tang,C. Janneke van der Woude,Paul Rutgeerts +11 more
TL;DR: Patients with moderate-to-severe Crohn's disease who were treated with infliximab plus azathioprine or inflIXimab monotherapy were more likely to have a corticosteroid-free clinical remission than those receiving azATHioprine monotherapy.
Journal ArticleDOI
Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.
Asher Kornbluth,David B. Sachar +1 more
TL;DR: Guidelines for clinical practice are aimed to indicate preferred approaches to medical problems as established by scientifically valid research, and are applicable to all physicians who address the subject regardless of specialty training or interests.
Journal ArticleDOI
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Simon Lichtiger,Daniel H. Present,Asher Kornbluth,Irwin M. Gelernt,Joel J. Bauer,Greg Galler,Fabrizio Michelassi,Stephen B. Hanauer +7 more
TL;DR: Intravenous cyclosporine therapy is rapidly effective for patients with severe corticosteroid-resistant ulcerative colitis.
Journal ArticleDOI
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.
Roopali Bansal Gupta,Noam Harpaz,Steven H. Itzkowitz,Sabera Hossain,Sierra Matula,Asher Kornbluth,Carol A. Bodian,Thomas A. Ullman +7 more
TL;DR: The severity of microscopic inflammation over time is an independent risk factor for developing advanced colorectal neoplasia among patients with long-standing UC.
Journal ArticleDOI
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
Laurent Peyrin-Biroulet,Walter Reinisch,Jean-Frederic Colombel,Gerassimos J. Mantzaris,Asher Kornbluth,Robert H. Diamond,Paul Rutgeerts,Linda K Tang,Freddy Cornillie,William J. Sandborn +9 more
TL;DR: Half the patients under azathioprine and/or infliximab in clinical remission have endoscopic and/ or CRP evidence of residual active CD, whereas other patients with endoscopicand CRP normalisation have persistent clinical symptoms.